| Literature DB >> 27357537 |
Andrea Di Cesare1, Carmen Losasso2, Lisa Barco2, Ester M Eckert1, Daniele Conficoni3, Giulia Sarasini1, Gianluca Corno1, Antonia Ricci2.
Abstract
Type II Toxin-Antitoxin systems (TAs), known for their presence in virulent and antibiotic resistant bacterial strains, were recently identified in Salmonella enterica isolates. However, the relationships between the presence of TAs (ccdAB and vapBC) and the epidemiological and genetic features of different non-typhoidal Salmonella serovars are largely unknown, reducing our understanding of the ecological success of different serovars. Salmonella enterica isolates from different sources, belonging to different serovars and epidemiologically unrelated according to ERIC profiles, were investigated for the presence of type II TAs, plasmid content, and antibiotic resistance. The results showed the ubiquitous presence of the vapBC gene in all the investigated Salmonella isolates, but a diverse distribution of ccdAB, which was detected in the most widespread Salmonella serovars, only. Analysis of the plasmid toxin ccdB translated sequence of four selected Salmonella isolates showed the presence of the amino acid substitution R99W, known to impede in vitro the lethal effect of CcdB toxin in the absence of its cognate antitoxin CcdA. These findings suggest a direct role of the TAs in promoting adaptability and persistence of the most prevalent Salmonella serovars, thus implying a wider eco-physiological role for these type II TAs.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27357537 PMCID: PMC4928088 DOI: 10.1038/srep28759
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Phenotypic and molecular characterization of the investigated Salmonella strains.
The dendrogram shows the similarity among the isolates tested by ERIC-PCR resulting in seven clusters: a–g. The source of isolation, phage-type, antibiotic resistance profile, toxin-antitoxin presence and plasmid profile of the isolates are listed. Ampicillin (A), chloramphenicol (Ch), ciprofloxacin (Cip), colistin (Col), florfenicol (F), nalidixic acid (Na), streptomycin (S), sulfamethoxazole (Su), tetracycline (T), and trimethoprim (Tr).
Figure 2Alignment of the aminoacidic CcdB sequence.
The arrow indicates the R99W mutation.
Primer pairs used to amplify antibiotic resistance genes.
| Target Name | Antibiotic class | Primer sequence (5′-3′) | Amplicon size (bp) | Annealing temperature (°C) | Reference |
|---|---|---|---|---|---|
| Tetracycline | 1-GCTACATCCTGCTTGCCTTC | 210 | 56 | ||
| 2-CATAGATCGCCGTGAAGAGG | |||||
| 1-TTCCTGTTTTTGCTCACCCAG | 112 | 58 | |||
| 2-CTCAAGGATCTTACCGCTGTTG | |||||
| 1-CGCTTTCCCATGATGAGCACCTTT | 110 | 58 | |||
| 2-TCCTGCTGGCGATAGTGGATCTTT | |||||
| Aminoglycosides | 126 | 54 | |||
| 2-CACCATGGCAAACAACCATA | |||||
| Aminoglycosides | 1-ATCGCTTTGCAGCTTTGTTT | 143 | 54 | ||
| 2-ATGATGCAGATCGCCATGTA | |||||
| Quinolones | 1-ATTTCTCACGCCAGGATTTG | 159 | 54 | ||
| 2-GCAGATCGGCATAGCTGAAG | |||||
| Quinolones | 1-GACGTGCTAACTTGCGTGAT | 118 | 54 | ||
| 2-TGGCATTGTTGGAAACTTG | |||||
| Sulphonamides | 1-TCCGGTGGAGGCCGGTATCTGG | 191 | 58 | ||
| 2-CGGGAATGCCATCTGCCTTGAG | |||||
| Sulphonamides | 1-TCCGTTCAGCGAATTGGTGCAG | 128 | 60 | ||
| 2-TTCGTTCACGCCTTACACCAGC |
Positive control strains.
| Bacterial strain | Antibiotic resistance gene (s) | Source |
|---|---|---|
| a | ||
| a | ||
| a | ||
| b | ||
| b | ||
| c |
a From the collection of Department of Food Safety, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy; b From the collection of Department of Surface Waters-Research and Management, Eawag: Swiss Federal Institute of Aquatic Science and Technology, Kastanienbaum, Switzerland; c From the collection of Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.